Disclosures for "Efficacy of Intensive Blood Pressure Lowering on Outcomes in Spontaneous Intraparenchymal Hemorrhage: A Meta-analysis "
-
Mr. Jordan has nothing to disclose.
-
Dr. Azeem has nothing to disclose.
-
Ms. Peterson has nothing to disclose.
-
Mr. Wesolowski has nothing to disclose.
-
An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.